Roivant Sciences (ROIV) Enterprise Value (2021 - 2026)

Roivant Sciences has reported Enterprise Value for 6 years, with the latest figure at -$3.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value rose 19.61% year-over-year to -$3.5 billion; the trailing twelve-month figure through Mar 2026 stood at -$3.5 billion (up 19.61% YoY), and the FY2026 full-year result was -$3.5 billion, up 19.61% from the prior year.
• Enterprise Value for Q1 2026 stood at -$3.5 billion, up from -$3.8 billion in the prior quarter.
• The five-year high for Enterprise Value was -$1.0 billion in Q2 2023, with the low at -$6.2 billion in Q4 2023.
• Historically, Enterprise Value has averaged -$3.0 billion across 5 years, with a median of -$2.9 billion in 2024.
• Annual changes were most pronounced in 2023 — Enterprise Value plunged 484.95% — and 2024, when it jumped 52.91%.
• Roivant Sciences' Enterprise Value stood at -$1.1 billion in 2022, then sank by 484.95% to -$6.2 billion in 2023, then jumped by 52.91% to -$2.9 billion in 2024, then plunged by 31.52% to -$3.8 billion in 2025, then grew by 7.8% to -$3.5 billion in 2026.
• The last three Enterprise Value figures came in at -$3.5 billion (Q1 2026), -$3.8 billion (Q4 2025), and -$3.9 billion (Q3 2025), per Business Quant data.